Here's a link to the Morgan's Healthcare weekly round up.
https://soundcloud.com/morgans-financial-limited/under-the-microscope-wrap-week-ending-22-november-2019
Friday's fall was most likely on the back of NAN being mentioned as part of a overvalued cohort of biotech stocks at the Sohn Hearts & Minds conference. Passive ETF's usually have algo's built in which react to certain "key words" and I think the selling was mainly an ETF dump. These types of sell downs provide an excellent opportunity for professional active investors to step up and get their fill.
I agree with the analyst's at Morgan's that the market has elected to look past the delay in the launch of the new product.
It's a structural growth business with a very large addressable market. Great management team with strong track record who are reinvesting heavily into pivot into different markets.
I think someone mentioned this in an earlier post, but the best way to look at NAN and the investment thesis is over a 5 years period. Believe there will be some great returns available for shareholders.
- Forums
- ASX - By Stock
- NAN
- result
result, page-49
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NAN (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.69 |
Change
-0.040(1.07%) |
Mkt cap ! $1.118B |
Open | High | Low | Value | Volume |
$3.73 | $3.80 | $3.69 | $3.321M | 894.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 45458 | $3.68 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.72 | 254 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 33368 | 3.680 |
2 | 5842 | 3.670 |
3 | 6094 | 3.660 |
1 | 5570 | 3.650 |
3 | 5964 | 3.640 |
Price($) | Vol. | No. |
---|---|---|
3.720 | 254 | 1 |
3.730 | 254 | 1 |
3.740 | 254 | 1 |
3.750 | 31556 | 3 |
3.760 | 5028 | 2 |
Last trade - 16.10pm 30/09/2024 (20 minute delay) ? |
Featured News
NAN (ASX) Chart |